Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Compare cheap dividend ETFs to identify which has the best yield, balancing income with cost. Explore top contenders and make an informed choice.
27,900 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Global equities outside the US have surged as growth improves and the dollar weakens. This article highlights three E...
A $7.6 billion ETF focused on smart grid infrastructure charges a 0.56% fee to capture AI power demand, centering on ...
A surge of XRP tokens flowed into Binance amid weekend geopolitical shocks, signaling potential near-term price press...
Bitcoin remains in a tight range as key U.S. data collide with inflation fears. Traders brace for a volatile weekend ...
Arthur Hayes, BitMEX co-founder and Maelstrom CIO, projects Bitcoin hitting $125K by year-end as liquidity returns. T...
A disciplined AI stock approach blends deep research with risk controls. Learn how this fund manager brilliant method...
U.S. and Japanese banks show divergent moves on XRP. Goldman Sachs dumped its XRP positions, Morgan Stanley added a t...
Bitcoin ETFs extended a fifth straight weekly decline, with late-day inflows offering a rare glimmer of optimism. Ana...
Bitcoin slides to $62K as the broader market weakens, but long bets rise in response, complicating the bitcoin price ...
A $10,000 SPY investment made the night of the 2024 election would be worth about $12,600 today, counting dividends. ...
New market analysis shows SPXL’s 3x exposure often falls short of its target because of daily resets and volatility d...